(-)-demecolcine decreases expression ISO ESCO2 (Homo sapiens) 6480464 Demecolcine results in decreased expression of ESCO2 mRNA CTD PMID:23649840 1,1-dichloroethene increases expression ISO Esco2 (Mus musculus) 6480464 vinylidene chloride results in increased expression of ESCO2 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ESCO2 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO Esco2 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of ESCO2 mRNA] CTD PMID:25210133 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ESCO2 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO Esco2 (Mus musculus) 6480464 Estradiol results in increased expression of ESCO2 mRNA CTD PMID:25210133 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Esco2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Esco2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO ESCO2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ESCO2 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ESCO2 mRNA CTD PMID:32109520 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Esco2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ESCO2 mRNA CTD PMID:21570461 and PMID:26377647 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases expression ISO Esco2 (Mus musculus) 6480464 Itraconazole results in decreased expression of ESCO2 mRNA CTD PMID:31099283 2-butoxyethanol increases expression ISO Esco2 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of ESCO2 mRNA CTD PMID:19812364 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Esco2 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of ESCO2 mRNA CTD PMID:25172293 3-methylcholanthrene increases expression ISO Esco2 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of ESCO2 mRNA CTD PMID:20713471 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ESCO2 mRNA CTD PMID:30047161 7,12-dimethyltetraphene increases expression ISO Esco2 (Mus musculus) 6480464 9 more ... CTD PMID:32553695 aflatoxin B1 increases expression ISO ESCO2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of ESCO2 mRNA CTD PMID:22100608 aflatoxin B1 increases methylation ISO ESCO2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of ESCO2 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO ESCO2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of ESCO2 mRNA CTD PMID:33167477 arsenite(3-) affects expression ISO ESCO2 (Homo sapiens) 6480464 arsenite affects the expression of ESCO2 mRNA CTD PMID:22959463 arsenite(3-) multiple interactions ISO ESCO2 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ESCO2 mRNA] CTD PMID:32406909 azathioprine decreases expression ISO ESCO2 (Homo sapiens) 6480464 Azathioprine results in decreased expression of ESCO2 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO ESCO2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ESCO2 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO ESCO2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ESCO2 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression ISO Esco2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ESCO2 mRNA CTD PMID:20713471 benzo[a]pyrene diol epoxide I increases expression ISO ESCO2 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 bis(2-chloroethyl) sulfide increases expression ISO Esco2 (Mus musculus) 6480464 Mustard Gas results in increased expression of ESCO2 mRNA CTD PMID:26392148 bis(2-ethylhexyl) phthalate decreases expression ISO Esco2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of ESCO2 mRNA CTD PMID:28085963 bisphenol A decreases expression ISO ESCO2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of ESCO2 mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ESCO2 mRNA CTD PMID:32145629 buta-1,3-diene increases expression ISO Esco2 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of ESCO2 mRNA CTD PMID:29038090 caffeine decreases phosphorylation ISO ESCO2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of ESCO2 protein CTD PMID:35688186 calcitriol decreases expression ISO ESCO2 (Homo sapiens) 6480464 Calcitriol results in decreased expression of ESCO2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO ESCO2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ESCO2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO Esco2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos decreases expression ISO Esco2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of ESCO2 mRNA CTD PMID:37019170 choline multiple interactions ISO Esco2 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:33549593 cisplatin increases expression ISO ESCO2 (Homo sapiens) 6480464 Cisplatin results in increased expression of ESCO2 mRNA CTD PMID:27594783 cobalt dichloride affects expression ISO ESCO2 (Homo sapiens) 6480464 cobaltous chloride affects the expression of ESCO2 mRNA CTD PMID:20105288 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ESCO2 mRNA CTD PMID:24386269 coumarin increases phosphorylation ISO ESCO2 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of ESCO2 protein CTD PMID:35688186 coumestrol increases expression ISO ESCO2 (Homo sapiens) 6480464 Coumestrol results in increased expression of ESCO2 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ESCO2 mRNA CTD PMID:26577399 cyanocob(III)alamin multiple interactions ISO Esco2 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:33549593 cyclosporin A decreases expression ISO ESCO2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ESCO2 mRNA CTD PMID:20106945 more ... dichloroacetic acid increases expression ISO Esco2 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of ESCO2 mRNA CTD PMID:28962523 dicrotophos decreases expression ISO ESCO2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of ESCO2 mRNA CTD PMID:28302478 dioxygen increases expression ISO Esco2 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of ESCO2 mRNA CTD PMID:22629407 dioxygen decreases expression ISO ESCO2 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of ESCO2 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO Esco2 (Mus musculus) 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ESCO2 mRNA] CTD PMID:22629407 diquat decreases expression ISO Esco2 (Mus musculus) 6480464 Diquat results in decreased expression of ESCO2 mRNA CTD PMID:36851058 dorsomorphin multiple interactions ISO ESCO2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ESCO2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO ESCO2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ESCO2 mRNA CTD PMID:30031762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ESCO2 mRNA CTD PMID:29391264 folic acid multiple interactions ISO Esco2 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:33549593 FR900359 affects phosphorylation ISO ESCO2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of ESCO2 protein CTD PMID:37730182 furan increases expression EXP 6480464 furan results in increased expression of ESCO2 mRNA CTD PMID:25539665 geldanamycin increases expression ISO ESCO2 (Homo sapiens) 6480464 geldanamycin results in increased expression of ESCO2 mRNA CTD PMID:26705709 glycine betaine multiple interactions ISO Esco2 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:33549593 gold atom decreases expression ISO ESCO2 (Homo sapiens) 6480464 Gold results in decreased expression of ESCO2 mRNA CTD PMID:25523186 gold(0) decreases expression ISO ESCO2 (Homo sapiens) 6480464 Gold results in decreased expression of ESCO2 mRNA CTD PMID:25523186 itraconazole decreases expression ISO Esco2 (Mus musculus) 6480464 Itraconazole results in decreased expression of ESCO2 mRNA CTD PMID:31099283 ketoconazole decreases expression ISO ESCO2 (Homo sapiens) 6480464 Ketoconazole results in decreased expression of ESCO2 mRNA CTD PMID:36621641 L-methionine multiple interactions ISO Esco2 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:33549593 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of ESCO2 mRNA CTD PMID:35283115 lucanthone decreases expression ISO ESCO2 (Homo sapiens) 6480464 Lucanthone results in decreased expression of ESCO2 mRNA CTD PMID:21148553 MeIQx increases expression ISO ESCO2 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20816883 methimazole increases expression EXP 6480464 Methimazole results in increased expression of ESCO2 mRNA CTD PMID:30047161 methyl methanesulfonate increases expression ISO ESCO2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ESCO2 mRNA CTD PMID:23649840 N-methyl-4-phenylpyridinium decreases expression ISO Esco2 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ESCO2 mRNA CTD PMID:17475336 N-nitrosodiethylamine multiple interactions ISO Esco2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:24535843 N-Nitrosopyrrolidine decreases expression ISO ESCO2 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of ESCO2 mRNA CTD PMID:32234424 nickel atom increases expression ISO ESCO2 (Homo sapiens) 6480464 Nickel results in increased expression of ESCO2 mRNA CTD PMID:25583101 ozone decreases expression ISO Esco2 (Mus musculus) 6480464 Ozone results in decreased expression of ESCO2 mRNA CTD PMID:24336422 ozone increases expression ISO Esco2 (Mus musculus) 6480464 Ozone results in increased expression of ESCO2 mRNA CTD PMID:33026818 ozone multiple interactions ISO Esco2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ESCO2 mRNA more ... CTD PMID:25658374 more ... paracetamol increases expression ISO ESCO2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ESCO2 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ESCO2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO ESCO2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ESCO2 mRNA CTD PMID:29067470 PCB138 multiple interactions ISO Esco2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO ESCO2 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of ESCO2 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO ESCO2 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of ESCO2 mRNA CTD PMID:36326898 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of ESCO2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO Esco2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA more ... CTD PMID:19482888 more ... phenobarbital increases expression ISO Esco2 (Mus musculus) 6480464 Phenobarbital results in increased expression of ESCO2 mRNA CTD PMID:19482888 more ... phenobarbital affects expression ISO Esco2 (Mus musculus) 6480464 Phenobarbital affects the expression of ESCO2 mRNA CTD PMID:19136022 pirinixic acid affects expression ISO Esco2 (Mus musculus) 6480464 pirinixic acid affects the expression of ESCO2 mRNA CTD PMID:19136022 pregnenolone 16alpha-carbonitrile increases expression ISO Esco2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of ESCO2 mRNA CTD PMID:22698814 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of ESCO2 mRNA CTD PMID:30047161 propanal decreases expression ISO ESCO2 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of ESCO2 mRNA CTD PMID:26079696 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ESCO2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO ESCO2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ESCO2 mRNA CTD PMID:27188386 senecionine increases expression EXP 6480464 senecionine results in increased expression of ESCO2 mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of ESCO2 mRNA CTD PMID:32419051 silicon dioxide decreases expression ISO ESCO2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of ESCO2 mRNA CTD PMID:23806026 silicon dioxide increases expression ISO Esco2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of ESCO2 mRNA CTD PMID:29341224 sodium arsenite affects expression ISO ESCO2 (Homo sapiens) 6480464 sodium arsenite affects the expression of ESCO2 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO ESCO2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ESCO2 mRNA CTD PMID:32844245 succimer multiple interactions ISO Esco2 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ESCO2 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ESCO2 mRNA CTD PMID:21641980 and PMID:26378955 succimer multiple interactions ISO ESCO2 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ESCO2 mRNA CTD PMID:26378955 sunitinib decreases expression ISO ESCO2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of ESCO2 mRNA CTD PMID:31533062 testosterone multiple interactions ISO ESCO2 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ESCO2 mRNA CTD PMID:21592394 testosterone decreases expression ISO ESCO2 (Homo sapiens) 6480464 Testosterone results in decreased expression of ESCO2 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO Esco2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ESCO2 mRNA CTD PMID:27339419 and PMID:31919559 thimerosal decreases expression ISO ESCO2 (Homo sapiens) 6480464 Thimerosal results in decreased expression of ESCO2 mRNA CTD PMID:27188386 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ESCO2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO ESCO2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of ESCO2 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO ESCO2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ESCO2 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO Esco2 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of ESCO2 mRNA CTD PMID:19042947 trovafloxacin decreases expression ISO Esco2 (Mus musculus) 6480464 trovafloxacin results in decreased expression of ESCO2 mRNA CTD PMID:35537566 urethane decreases expression ISO ESCO2 (Homo sapiens) 6480464 Urethane results in decreased expression of ESCO2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO ESCO2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ESCO2 mRNA CTD PMID:28001369 vincristine decreases expression ISO ESCO2 (Homo sapiens) 6480464 Vincristine results in decreased expression of ESCO2 mRNA CTD PMID:23649840 vorinostat affects expression ISO ESCO2 (Homo sapiens) 6480464 vorinostat affects the expression of ESCO2 mRNA CTD PMID:27188386 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of ESCO2 mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO Esco2 (Mus musculus) 6480464 squalestatin 1 results in decreased expression of ESCO2 mRNA CTD PMID:27225895 zinc atom multiple interactions ISO Esco2 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO Esco2 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of ESCO2 mRNA CTD PMID:33549593 zoledronic acid increases expression ISO ESCO2 (Homo sapiens) 6480464 zoledronic acid results in increased expression of ESCO2 mRNA CTD PMID:20977926